BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7547353)

  • 1. Aerosol administration of antibiotics.
    Smith AL; Ramsey B
    Pediatr Pulmonol Suppl; 1995; 11():68-9. PubMed ID: 7547353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro characteristics of tobramycin aerosol from ultrasonic and jet nebulizers.
    Asmus MJ; Milavetz G; Tice AL; Teresi ME
    Pharmacotherapy; 2001 May; 21(5):534-9. PubMed ID: 11349742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nebulizer configuration on delivery of aerosolized tobramycin.
    O'Riordan TG; Amram JC
    J Aerosol Med; 1997; 10(1):13-23. PubMed ID: 10166359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalation of tobramycin in cystic fibrosis. Part 2: optimization of the tobramycin solution for a jet and an ultrasonic nebulizer.
    Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW
    Int J Pharm; 1999 Nov; 189(2):215-25. PubMed ID: 10536250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of nebulized antibiotics in treating serious respiratory infections.
    Cole PJ
    J Chemother; 2001 Aug; 13(4):354-62. PubMed ID: 11589477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nebulizer type and antibiotic concentration on device performance.
    Weber A; Morlin G; Cohen M; Williams-Warren J; Ramsey B; Smith A
    Pediatr Pulmonol; 1997 Apr; 23(4):249-60. PubMed ID: 9141110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosol administration of antibiotics.
    Smith AL; Ramsey B
    Respiration; 1995; 62 Suppl 1():19-24. PubMed ID: 7792435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols.
    Coates AL; MacNeish CF; Meisner D; Kelemen S; Thibert R; MacDonald J; Vadas E
    Chest; 1997 May; 111(5):1206-12. PubMed ID: 9149571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.
    Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW
    Int J Pharm; 1999 Nov; 189(2):205-14. PubMed ID: 10536249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulized tobramycin in patients with chronic respiratory infections during clinical evolution of Wegener's granulomatosis.
    Terzano C; Taurino AE; Peona V
    Eur Rev Med Pharmacol Sci; 2001; 5(4):131-8. PubMed ID: 12067081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the availability of tobramycin for inhalation from vented vs unvented nebulizers.
    Coates AL; MacNeish CF; Lands LC; Meisner D; Kelemen S; Vadas EB
    Chest; 1998 Apr; 113(4):951-6. PubMed ID: 9554630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-Pseudomonas aerosol therapy in cystic fibrosis: improvement with tobramycin].
    Foucaud P; Borel B; Charara O; Nathanson S; Petitprez P; Pin I
    Rev Pneumol Clin; 2002 Jun; 58(3 Pt 1):131-8. PubMed ID: 12486796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic approaches to chronic cystic fibrosis respiratory infections with available, emerging aerosolized antibiotics.
    Ballmann M; Smyth A; Geller DE
    Respir Med; 2011 Dec; 105 Suppl 2():S2-8. PubMed ID: 22208546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro aerodynamic characterization of the dose emitted during nebulization of tobramycin high strength solution by novel and jet nebulizer delivery systems.
    Mashat M; Clark BJ; Assi KH; Chrystyn H
    Pulm Pharmacol Ther; 2016 Apr; 37():37-42. PubMed ID: 26747025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Comparison of a Vibrating Mesh Nebulizer Operating in Inspiratory Synchronized and Continuous Nebulization Modes During Noninvasive Ventilation.
    Michotte JB; Staderini E; Le Pennec D; Dugernier J; Rusu R; Roeseler J; Vecellio L; Liistro G; Reychler G
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):328-36. PubMed ID: 27310926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of aerosolized antibiotics in cystic fibrosis patients.
    Moss RB
    Chest; 2001 Sep; 120(3 Suppl):107S-113S. PubMed ID: 11555564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis.
    Falagas ME; Kasiakou SK
    Infection; 2007 Feb; 35(1):3-10. PubMed ID: 17297582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosolized antibiotics in mechanically ventilated patients: delivery and response.
    Palmer LB; Smaldone GC; Simon SR; O'Riordan TG; Cuccia A
    Crit Care Med; 1998 Jan; 26(1):31-9. PubMed ID: 9428540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term tobramycin aerosol therapy in cystic fibrosis.
    Steinkamp G; Tümmler B; Gappa M; Albus A; Potel J; Döring G; von der Hardt H
    Pediatr Pulmonol; 1989; 6(2):91-8. PubMed ID: 2494640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhaled antibiotic therapy in cystic fibrosis].
    Girón Moreno RM; Salcedo Posadas A; Mar Gómez-Punter R
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():14-8. PubMed ID: 21703474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.